Open AccessTurmeric for Treatment of Irritable Bowel Syndrome: A Systematic Review of Population-Based Evidence
Author(s) -
Emad Jafarzadeh,
Shahram Shoeibi,
Yaser Bahramvand,
Elham Nasrollahi,
Armin Salek Maghsoudi,
Fatemeh Yazdi,
Sepideh Karkon-Shayan,
Shokoufeh Hassani
Publication year - 2022
Publication title -
iranian journal of public health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.452
H-Index - 39
eISSN - 2251-6093
pISSN - 2251-6085
DOI - 10.18502/ijph.v51i6.9656
Subject(s) - curcumin , irritable bowel syndrome , medicine , abdominal pain , disease , clinical trial , population , quality of life (healthcare) , web of science , alternative medicine , randomized controlled trial , traditional medicine , intensive care medicine , meta analysis , pharmacology , pathology , nursing , environmental health
Irritable bowel syndrome (IBS) is a highly prevalent disorder of the gut interaction characterized by abdominal discomfort and pain associated with altered bowel habits in the absence of structural abnormalities. In spite of IBS' high prevalence and disease burden across the globe, no explanations have been given as to its underlying pathophysiology. As for the treatment of IBS, there is no specific medication, and the most beneficial treatment is usually supportive therapy. Recent animal and human studies have demonstrated the therapeutic potential of curcumin or turmeric in the treatment of IBS.